These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26298838)
1. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry. Prater J; Valeri F; Korol D; Rohrmann S; Dehler S J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for contralateral breast cancer in Chennai (Madras), India. Gajalakshmi CK; Shanta V; Hakama M Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728 [TBL] [Abstract][Full Text] [Related]
3. Incidence of metachronous contralateral breast cancer in Denmark 1978-2009. Rasmussen CB; Kjær SK; Ejlertsen B; Andersson M; Jensen MB; Christensen J; Langballe R; Mellemkjær L Int J Epidemiol; 2014 Dec; 43(6):1855-64. PubMed ID: 25326461 [TBL] [Abstract][Full Text] [Related]
4. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645 [TBL] [Abstract][Full Text] [Related]
5. Contralateral breast cancer: annual incidence and risk parameters. Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B J Clin Oncol; 1995 Jul; 13(7):1578-83. PubMed ID: 7602346 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses. Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018 [TBL] [Abstract][Full Text] [Related]
7. Second cancers following in situ carcinoma of the breast. Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601 [TBL] [Abstract][Full Text] [Related]
8. [Contralateral breast cancer: metastasis or second primary cancer?]. Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638 [TBL] [Abstract][Full Text] [Related]
9. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women. Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870 [TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer. Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811 [TBL] [Abstract][Full Text] [Related]
11. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ. Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780 [TBL] [Abstract][Full Text] [Related]
12. Reproductive history and risk of second primary breast cancer: the WECARE study. Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614 [TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983 [TBL] [Abstract][Full Text] [Related]
14. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients. Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092 [TBL] [Abstract][Full Text] [Related]
15. Genetic implications of bilateral breast cancer: a population based cohort study. Hartman M; Czene K; Reilly M; Bergh J; Lagiou P; Trichopoulos D; Adami HO; Hall P Lancet Oncol; 2005 Jun; 6(6):377-82. PubMed ID: 15925815 [TBL] [Abstract][Full Text] [Related]
16. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study. Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521 [TBL] [Abstract][Full Text] [Related]
17. Second primary in the contralateral breast after treatment of breast cancer. Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777 [TBL] [Abstract][Full Text] [Related]
18. Patterns of metastasis in women with metachronous contralateral breast cancer. Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M Br J Cancer; 2012 Jul; 107(2):221-3. PubMed ID: 22735901 [TBL] [Abstract][Full Text] [Related]
19. Contralateral breast cancer: clinical characteristics and impact on prognosis. Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193 [TBL] [Abstract][Full Text] [Related]
20. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Gao X; Fisher SG; Emami B Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]